Systematic review / meta-analysis / 2011
Vitamin D3 supplementation significantly decreased mortality in adults, while vitamin D2, alfacalcidol, and calcitriol showed no significant effect.
A Cochrane systematic review examined 50 randomized trials encompassing 94,148 participants (mostly elderly women older than 70 years) given vitamin D for a median of two years. Overall, vitamin D decreased mortality (RR 0.97, 95% CI 0.94 to 1.00). When analyzed by form, only vitamin D3 significantly reduced mortality (RR 0.94, 95% CI 0.91 to 0.98; 32 trials, 74,789 participants), whereas vitamin D2, alfacalcidol, or calcitriol did not. However, vitamin D3 combined with calcium increased the risk of nephrolithiasis (RR 1.17, 95% CI 1.02 to 1.34), and alfacalcidol and calcitriol increased the risk of hypercalcemia (RR 3.18, 95% CI 1.17 to 8.68).
- Study type
- Systematic review and meta-analysis of randomized trials
- Who was studied
- 94,148 participants across 50 randomized trials, mostly elderly women (older than 70 years)
- What was measured
- All-cause mortality, nephrolithiasis, hypercalcaemia, and health-related quality of life
THE PAPER
Vitamin D supplementation for prevention of mortality in adults.
Bjelakovic G, Gluud LL, Nikolova D, Whitfield K, Wetterslev J, Simonetti RG, Bjelakovic M, Gluud C. Cochrane Database Syst Rev, 2011.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.